November 13th, 2026Dupilumab for early EoE linked to lower asthma risk in young childrenIn a matched cohort of children aged 6 and younger with EoE, dupilumab was linked to less incident asthma than swallowed budesonide (10.5% vs 16.2%).Read more
November 12th, 2026Risankizumab shows 52-week efficacy in pediatric psoriasis trialFull OptIMMize-1 results show high skin clearance rates with risankizumab in children and teens with psoriasis, sustained through 52 weeks.Read more
November 10th, 2026Cariprazine improves mania and depression in pediatric bipolar IPost hoc data show cariprazine improved both manic and depressive symptoms through 52 weeks in youth aged 10 to 17 years with bipolar I disorder.Read more
November 4th, 2026November 2026 preview: 4 FDA decisions to watch in pediatric careFind out the 4 FDA decisions to watch in November 2026 for pediatric care.Read more
November 4th, 2026Cenobamate sNDAs seek PGTC and pediatric focal seizure indicationsCenobamate sNDAs target PGTC seizures in patients ≥12 years and pediatric focal seizures; phase 3 PGTC data showed a 71.9% median reduction.Read more
November 3rd, 2026FDA approves Lupin's generic amifampridine for LEMSFDA approved Lupin's generic of Firdapse for LEMS in patients 6 years and older, but a patent settlement delays US marketing until at least 2035.Read more
November 2nd, 2026Clinical trial news in pediatrics: October 2026A recap of the top pediatric clinical trial results and pipeline data readouts during October 2026.Read more
November 2nd, 2026FDA news in pediatrics: October 2026A recap of the top FDA approvals, regulatory decisions, and pipeline updates affecting pediatric care during October 2026.Read more